Main Line Center for Skin Surgery
191 Presidential Blvd, Suite LN24
Bala Cynwyd, PA
Phone: 610-664-1414 
Fax: 610-572-7262


New drugs target advanced melanoma

 

New hope for patients with advanced melanoma came at last with the appearance of the first generation of drugs to target melanomas with specific gene mutations. Vemurafenib (Zelboraf) has been shown to prolong survival in patients with metastatic melanoma and is currently the only FDA approved drug that targets melanomas with BRAF mutations. Two new oral medications (trametinib and dabrafenib) have recently been shown to slow down the progression of advanced melanoma as well and are undergoing further study before FDA approval.

2012 Annual Meeting of the American Society of Clinical Oncology

Ultraviolet Radiation declared a human carcinogen by the World Health Organization

In June 2009, the International Agency for Research on Cancer reassessed the types of radiation known to cause cancer in humans. Included on the IARC list is ultraviolet radiation from sun exposure and indoor tanning booths. An analysis of over 20 studies shows that the risk of developing melanoma is increased by 75% when the use of tanning beds starts before age 30 ! (IARC media center)These findings reinforce the previous WHO recommendations to avoid indoor tanning booths and to protect your skin from over exposure to the sun.